izpis_h1_title_alt

Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta
Lunder, Mojca (Avtor), Žiberna, Lovro (Avtor), Janić, Miodrag (Avtor), Jerin, Aleš (Avtor), Skitek, Milan (Avtor), Šabovič, Mišo (Avtor), Drevenšek, Gorazd (Avtor)

URLURL - Predstavitvena datoteka, za dostop obiščite http://link.springer.com/content/pdf/10.1007%2Fs00380-012-0259-0.pdf Novo okno

Izvleček
Statins and angiotensin receptor blockers at therapeutic doses have beneficial cardiovascular effects, which can be applied for cardiovascular protection. We explored whether low doses of atorvastatin, losartan, and particularly their combination, possess important pleiotropic vasodilatory effects. Wistar rats were treated daily with low-dose atorvastatin (2 mg/kg, n= 15), low-dose losartan (5 mg/kg, n = 15), their combination (n = 15), or saline (n = 15). After 4, 6, or 8 weeks the animals were anesthetized, blood samples taken, and their hearts and thoracic aortas isolated. Two kinds of experiments were performed: the measurement of coronary flow rate after ischemia/reperfusion myocardial injury and endothelium-dependent relaxation ofthoracic aorta. In both models, maximal vasodilation activity was obtained in rats treated for 6 weeks. In the ischemia/reperfusion myocardial injury model, coronary flow increased (atorvastatin or losartan 1.9-fold, P < 0.01; combination 2.4-fold, P < 0.001) compared with controls. In the thoracic aorta model, endothelium-dependent relaxation significantly increased only in the combination group compared with the control group (up to 1.4-fold; P < 0.01). Simultaneously, we detected increased anti-inflammatory activity and increased nitric oxide concentration, but no changes in lipids and blood pressure. In a rat model we showed important vasodilatory activity of low-doseatorvastatin, losartan, and particularly their combination. The effects of the low-dose combination were accompanied by, and probably at least partly achieved by, anti-inflammatory and nitric oxide pathways. Overall,these results could be valuable for the development of new vascular protective strategies focusing on a low-dose regimen of statins and sartans, and particularly their combination.

Jezik:Angleški jezik
Ključne besede:statini, atorvastatin, losartan, kardiovaskularne bolezni, zdravljenje
Vrsta gradiva:Delo ni kategorizirano (r6)
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2013
Št. strani:str. 246-254
Številčenje:Vol. 28, issue 2
UDK:615.22:616.1
ISSN pri članku:0910-8327
DOI:10.1007/s00380-012-0259-0 Povezava se odpre v novem oknu
COBISS.SI-ID:3436657 Povezava se odpre v novem oknu
Število ogledov:476
Število prenosov:127
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
 
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
:
Objavi na: Bookmark and Share

Gradivo je del revije

Naslov:Heart and vessels
Skrajšan naslov:Heart vessels
Založnik:Springer Internat.
ISSN:0910-8327
COBISS.SI-ID:12938713 Novo okno

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj